Larvol Delta - Cytisinicline-for-smoking-cessation-among-patients-with-a-history-of-cancer-A-posthoc-analysis-from-two-phase-3-clinical-trials

Tabex (cytisinicline) - Achieve Life Sciences

https://www.asco.org/abstracts-presentations/265685/

Don Dizon; Matthew Linley-Adams; Mark Rubinstein

Apr 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next